Evidence & Insights › News
Press features, media mentions and listicle placements highlighting iNGENū’s leadership in physician-led, AI-powered clinical research.
Featured
March 2026
Frost & Sullivan's Growth Opportunity News analysis of how iNGENū CRO is reshaping the Asia-Pacific biotech CRO landscape through physician leadership, AI-driven automation, and a disciplined, technology-native operating model — the basis for iNGENū's 2026 Asia-Pacific Biotech CRO Customer Value Leadership Award.
Read coverage ↗Recent placements
2026
Recently published feature on iNGENū CRO in the International Clinical Trials journal — see pages 17–19 for the full article on our physician-led, AI-powered approach to trial execution.
Read article ↗February 2026
iNGENū CRO named among the top contract research organisations to watch in 2026 for its physician-led leadership, AI-powered operations, and fixed-milestone commercial model.
Read article ↗December 2025
Reuters press release coverage of iNGENū CRO's approach to cost-efficient clinical trial delivery for early-stage biotech sponsors.
Read article ↗December 2025
An editorial review of the Australian CRO landscape and why physician ownership, R&D Tax Incentive eligibility, and decentralised infrastructure are reshaping sponsor decisions.
Read article ↗2025
IBTimes coverage of iNGENū's leadership in FDA-compliant decentralised clinical trials across the Asia-Pacific region.
Read article ↗March 2025
Tech Times feature on how iNGENū CRO helps biotech companies navigate financial headwinds in 2025 through cost-efficient trial strategies.
Read article ↗For interviews, commentary or media assets, contact our team at hello@ingenucro.com.
Request a proposal